AEON - AEON Biopharma, Inc.
0.494
-0.039 -7.976%
Share volume: 274,707
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.04
-0.07%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 07-21-2023 | 05-14-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 13.046 M | 13.971 M | 10.381 M | 7.760 M | 4.016 M | 5.667 M | |
| Selling general and admin | 3.841 M | 4.946 M | 4.649 M | 3.321 M | 3.044 M | 2.629 M | |
| Research and development | 9.205 M | 9.025 M | 5.732 M | 4.439 M | 972.000 K | 3.038 M | |
| Total expenses | 13.046 M | 13.971 M | 74.150 M | -153.473 M | 4.016 M | 2.322 M | |
| 7.09% | 430.74% | -306.98% | 102.62% | -42.18% | |||
| Operating income | -13.046 M | -13.971 M | -74.150 M | 153.473 M | -4.016 M | -2.322 M | |
| Ebit | -17.639 M | -15.379 M | -118.018 M | 164.112 M | -6.171 M | 1.987 M | |
| Pretax income | -17.639 M | -15.379 M | -118.018 M | 164.112 M | -6.171 M | 2.082 M | |
| -12.81% | 667.40% | -239.06% | -103.76% | -133.74% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -17.639 M | -15.379 M | -118.018 M | 164.112 M | -6.171 M | 2.082 M | |
| 12.81% | -667.40% | 239.06% | -103.76% | 133.74% |
